State of Wisconsin Investment Board
NRIX icon

State of Wisconsin Investment Board’s Nurix Therapeutics NRIX Stock Holding History

State of Wisconsin Investment Board’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Buy
34,421
+906
+3% +$15K ﹤0.01% 1965
2025
Q4 		$636K Sell
33,515
-6,243
-16% -$89.7K ﹤0.01% 1839
2025
Q3 		$367K Sell
39,758
-53,642
-57% -$557K ﹤0.01% 2026
2025
Q2 		$1.06M Sell
93,400
-996
-1% -$10.8K ﹤0.01% 1548
2025
Q1 		$1.12M Buy
94,396
+44,270
+88% +$740K ﹤0.01% 1453
2024
Q4 		$944K Buy
50,126
+13,030
+35% +$299K ﹤0.01% 1554
2024
Q3 		$834K Buy
37,096
+1,958
+6% +$44.4K ﹤0.01% 1634
2024
Q2 		$733K Buy
+35,138
New +$547K ﹤0.01% 1653
2024
Q1 		– Sell
-23,891
Closed -$247K – 2359
2023
Q4 		$247K Sell
23,891
-3,757
-14% -$25.7K ﹤0.01% 2133
2023
Q3 		$217K Sell
27,648
-349
-1% -$3.19K ﹤0.01% 2209
2023
Q2 		$280K Sell
27,997
-1,278
-4% -$13K ﹤0.01% 2021
2023
Q1 		$260K Sell
29,275
-3,227
-10% -$33.6K ﹤0.01% 2166
2022
Q4 		$357K Sell
32,502
-1,893
-6% -$22.8K ﹤0.01% 2033
2022
Q3 		$448K Buy
34,395
+9,602
+39% +$152K ﹤0.01% 2028
2022
Q2 		$314K Sell
24,793
-15,707
-39% -$178K ﹤0.01% 2309
2022
Q1 		$567K Hold
40,500
– – ﹤0.01% 1766
2021
Q4 		$1.17M Hold
40,500
– – ﹤0.01% 1402
2021
Q3 		$1.21M Hold
40,500
– – ﹤0.01% 1395
2021
Q2 		$1.07M Buy
40,500
+24,800
+158% +$728K ﹤0.01% 1431
2021
Q1 		$488K Hold
15,700
– – ﹤0.01% 1607
2020
Q4 		$516K Buy
+15,700
New +$520K ﹤0.01% 1530

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

State of Wisconsin Investment Board's NRIX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Nurix Therapeutics (NRIX) stake by 2.7% in Q1 2026, buying an estimated $15K and bringing the position to 34,421 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

State of Wisconsin Investment Board first reported a position in NRIX in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.21M in Q3 2021. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • State of Wisconsin Investment Board held 34,421 shares of Nurix Therapeutics worth $534K as of Q1 2026.
  • State of Wisconsin Investment Board bought 906 Nurix Therapeutics shares in Q1 2026, an estimated $15K.
  • Nurix Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1965 holding.
  • State of Wisconsin Investment Board first reported a position in Nurix Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • State of Wisconsin Investment Board's Nurix Therapeutics position peaked at $1.21M in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.